Cell Therapy BioCollagen Platform Life Science About RMS News Room IRS Support
Cell Therapy
ADIFORM
DERMAN
BABYCELL
BioCollagen
THERACOL®
RMS BioCollagen™
Liposome™
THERAFILL®
THERAFORM™
NOVOSTRATA
Platform
Platform
Operating Software
Apparatus & Instrument
Life Science
GLP Service
CRO Service
Labware
Regent
About RMS
Overview
Company Background
History
Market
Certificate
Location
Bio-Network
News Room
News Releases
Exhibition Schedule
IRS
About IRS
News & Journals
Member Services
Global Network
Support
Contact
Download
News Releases
TheraForm, received 510(k) clearance from the FDA
Sewon Cellontech has announced that TheraForm™ Standard and Sheet types have been cleared for marketing in the United States of America through the 510(k) Premarket Notification. Theraform is intended for the management of wound d...
Date : Sep 01, 2009
Collagen filler product passed NAMSA’s safety test
Sewon Cellontech has passed the safety test performed by NAMSA for the own developed collagen filler product, called Therafill®. The company adds to say that they are on the processing for IRB approval of the clinical trials in Korea and it is expected to launch Therafill® i...
Date : Jun 12, 2007
Sewon Cellontech, establishing a JV with a Thai company
Sewon Cellontech announced that a Joint Venture named RMS THAILAND will be established in Bangkok, funding with a Thai company Cellular Beauty on June 7, 2007. RMS THAILNAD is going to install H class RM Platform which can produce regenerative medical therapeutics to tre...
Date : Jun 12, 2007
Sewon Cellontech established a British JV with UCL Business
Sewon Cellontech Co., Ltd. finally signed the agreement of Joint Venture to established ‘RMS Innovations (U.K.) Limited’ in U. K. with University College London Business PLC as of 9th of May. It is anticipated that regenerative therapeutic treatments based on advance techniq...
Date : May 10, 2007
MOU agreed by Sewon Cellontech and Biomet in the Netherlands
Sewon Cellontech has agreed Memorandum of Understanding with Biomet Netherland B.V. to supply three units of RMS platform and RMS M-class of Cartilage therapy. The platforms to be installed are C-class type and they are going to be installed in 3 sites nationwide in Netherla...
Date : May 07, 2007
Sewon Cellontech acquired Patent for module device– RM Platform of producing and storing for cell therapeutics.
Sewon Cellontech has acquired a patent for ‘module device of producing and storing for cell therapeutics’ which is standardized and modulized in order to enable engagement and installment with each functional part of several facilities and equipment at site related to RMS. R...
Date : May 07, 2007
      1 2 3 4 [5] 6 7